Renal mass biopsy is accurate for small renal masses (4 cm or less), according to a study published in the March issue of The Journal of Urology. Hwang Gyun Jeon, MD, from the Sungkyunkwan University ...

Renal mass biopsy is generally safe. Minor complications occur in approximately 5% of all biopsies and major complications are rare. 12 The most common complication is bleeding, which is often ...

Biopsy of small renal masses (SRMs) that look like renal cell carcinoma (RCC) continues to be debated and most patients undergo treatment without tissue diagnosis. At least 20% of SRMs are benign and ...

The accuracy and reliability of percutaneous renal biopsy has been much debated. Tissue-based diagnostic assessment remains important, because although CT, ultrasonography and MRI can accurately ...

Current Management of Small Renal Masses, Including Patient Selection, Renal Tumor Biopsy, Active Surveillance, and Thermal Ablation. If you have the appropriate software installed, you can download ...

Neutrophil-to-lymphocyte ratio as a predictor of oncologic outcomes in locally advanced non-metastatic clear cell renal carcinoma. This is an ASCO Meeting Abstract from the 2020 Genitourinary Cancers ...

The incidence of renal cell carcinoma is increasing, in part due to the growing use of cross-sectional imaging. Most renal tumors are now incidentally detected as small masses in asymptomatic patients ...

When diagnosed at a localized stage, renal cell carcinoma (RCC) is generally treated with surgical removal of either the entire kidney or a portion containing a tumor and has a 5-year survival rate of ...

Minimally invasive, nephron-sparing surgical approaches are considered the gold standard for management of small renal masses. But what about patients who are interested in avoiding treatment; ...

Please provide your email address to receive an email when new articles are posted on . A small trial that compared radiofrequency ablation with stereotactic body radiation therapy for small renal ...

The growth rates of small renal masses (SRMs) are highly variable early on during active surveillance, especially in the first 6 to 12 months, but this decreases with time and does not portend death ...

NIJMEGEN, Netherlands & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Aiosyn, a pioneering pathology software company specializing in AI-powered solutions for cancer and kidney disease, and Pramana, an industry ...